首页> 外文期刊>The European journal of health economics: HEPAC : health economics in prevention and care >The true impact of the French pay-for-performance program on physicians' benzodiazepines prescription behavior
【24h】

The true impact of the French pay-for-performance program on physicians' benzodiazepines prescription behavior

机译:法国按绩效付费计划对医生的苯二氮卓类药物处方行为的真正影响

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Objectives The French pay-for-performance (P4P) contract CAPI implemented by the national health insurance included a target-goal which aims at reducing benzodiazepines prescriptions. In this investigation, we would like to assess whether: (1) the general practitioners (GPs) having signed P4P contract obtain better results regarding the target-goal than non-signatories; (2) (part of) this progression is due to the CAPI contract itself (tentative measurement of a "causal effect''); (3) (part of) the money spent on this P4P incentive can be self-financed with the amount of pharmaceuticals saved.
机译:目标由国家健康保险实施的法国按绩效付费(P4P)合同CAPI包括一个目标目标,旨在减少苯二氮卓类药物的处方。在这项调查中,我们想评估一下:(1)签订P4P合同的全科医生(GP)在目标目标方面的成绩要好于非签字方; (2)(部分)进展是由于CAPI合同本身(“因果效应”的初步衡量);(3)(部分)在此P4P激励上花费的资金可以由金额自筹节省的药品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号